MDSpire - Takeaway
Feature

The Past, Present and Future of Non-Target Screening

Thomas Letzel reflects on the evolution of non-target screening and why interdisciplinary insights are key to its future

  • March 23, 2026

  • 9 min

Share

  • 1

    Non-target screening (NTS) explores unknown compounds.

  • 2

    AFIN-TS facilitates NTS implementation in labs.

  • 3

    Key techniques include mass spectrometry & chromatography.

  • 4

    Major challenges include data management.

  • 5

    Interdisciplinary collaboration enhances NTS applications.

  • 6

    Ongoing training is vital for future developments.

  • 7

    Participants can expect diverse insights from the upcoming symposium.

  • 8

    Public understanding of NTS is crucial for broader adoption.

Original Source(s)

The Past, Present and Future of Non-Target Screening

  • March 23, 2026

Related Content

Metabolic Acidosis Care Limited in Chronic Kidney Disease

Low testing rates may contribute to underdiagnosis and undertreatment in Japan

Influencer Drug Promotion Raises Concerns

Study highlights regulatory gaps and persuasive risks in social media marketing

From Crisis to Compliance: Navigating Europe’s Toughest Medical Device Rules

Compliance is no longer a background function — it is central to maintaining access